← Browse by Condition
Medical Condition

sars cov 2

Total Trials
3
Recruiting Now
3
Trial Phases
Phase 4, Phase 1
NCT07266558 Phase 4
Recruiting

A Study to Evaluate the Efficacy and Safety of mRNA-1283 and mRNA-1273 in Participants 50 to 64 Years of Age Without High-Risk Conditions for Severe Coronavirus Disease 2019 (COVID-19)

Enrollment
30,000 pts
Location
United States
Sponsor
ModernaTX, Inc.
View Trial →
NCT04448145
Recruiting

Determinants of SARS (Severe Acute Respiratory Syndrome)-COV2 (COVID-19) Persistence After Convalescence

Enrollment
800 pts
Location
United States
Sponsor
Columbia University
View Trial →
NCT07416539 Phase 1
Recruiting

Effect of COV2 Vaccine Formulation on the Ability to Generate Antibodies Against Coronavirus That Causes COVID-19

Enrollment
20 pts
Location
Finland
Sponsor
Rokote Laboratories Finland Oy
View Trial →